Effect of lactoferrin on consequences of acute experimental hemorrhagic anemia in rats

Bull Exp Biol Med. 2010 Aug;149(2):219-22. doi: 10.1007/s10517-010-0911-6.
[Article in English, Russian]

Abstract

The effect of human lactoferrin on the arrest of experimental hemorrhagic anemia consequences was studied in rats. After six blood losses (days 1-4 and 7-8 of the experiment), the rats developed acute anemia: hemoglobin concentration decreased to 59% of the initial level, serum iron level decreased 3-fold. Intraperitoneal injections of lactoferrin (10 mg/day) for 4 days starting from day 7 led to an increase in hemoglobin level to 109% and of serum iron to 125% on day 14. In controls, hemoglobin level on day 14 was 70% and iron content 49% of the initial level. Ferroxidase activity of ceruloplasmin in blood serum decreased after 5 blood losses returned to normal only in rats receiving lactoferrin. The results indicate that lactoferrin modified ceruloplasmin activity in vivo, promoting normalization of iron metabolism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anemia / drug therapy*
  • Animals
  • Ceruloplasmin / metabolism
  • Chromatography, Ion Exchange
  • Erythrocyte Indices / drug effects
  • Humans
  • Injections, Intraperitoneal
  • Iron / blood
  • Iron / metabolism*
  • Lactoferrin / administration & dosage
  • Lactoferrin / pharmacology*
  • Lactoferrin / therapeutic use*
  • Male
  • Milk, Human / chemistry
  • Rats
  • Rats, Wistar

Substances

  • Iron
  • Ceruloplasmin
  • Lactoferrin